• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新冠病毒的感染、免疫与监测。

Infection, immunity, and surveillance of COVID-19.

机构信息

Centers for Disease Control and Prevention, Atlanta, United States of America.

Department of Biology, University of Oxford, Oxford, United Kingdom.

出版信息

PLoS Med. 2022 Nov 10;19(11):e1004132. doi: 10.1371/journal.pmed.1004132. eCollection 2022 Nov.

DOI:10.1371/journal.pmed.1004132
PMID:36356041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9648838/
Abstract

Dr Amitabh Suthar and Dr Christopher Dye give their perspective on infection, immunity and surveillance of COVID-19.

摘要

阿米塔布·苏塔尔博士和克里斯托弗·戴伊博士分享了他们对 COVID-19 的感染、免疫和监测的看法。

相似文献

1
Infection, immunity, and surveillance of COVID-19.新冠病毒的感染、免疫与监测。
PLoS Med. 2022 Nov 10;19(11):e1004132. doi: 10.1371/journal.pmed.1004132. eCollection 2022 Nov.
2
Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy.抗逆转录病毒疗法与人群死亡率：利用常规国家数据推进政策。
PLoS Med. 2017 Dec 12;14(12):e1002469. doi: 10.1371/journal.pmed.1002469. eCollection 2017 Dec.
3
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.人类对轻度与重度 COVID-19 感染免疫的系统生物学评估。
Science. 2020 Sep 4;369(6508):1210-1220. doi: 10.1126/science.abc6261. Epub 2020 Aug 11.
4
Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review.流式细胞术检测 COVID-19 患者单核细胞 HLA-DR：一项中期综述。
Cytometry A. 2020 Dec;97(12):1217-1221. doi: 10.1002/cyto.a.24249. Epub 2020 Nov 4.
5
A public health approach to hepatitis C control in low- and middle-income countries.低收入和中等收入国家丙型肝炎防控的公共卫生方法。
PLoS Med. 2015 Mar 10;12(3):e1001795. doi: 10.1371/journal.pmed.1001795. eCollection 2015 Mar.
6
Case Report: Interferon- γ Rescues Monocytic Human Leukocyte Antigen Receptor (mHLA-DR) Function in a COVID-19 Patient With ARDS and Superinfection With Multiple MDR 4MRGN Bacterial Strains.病例报告：干扰素-γ挽救 COVID-19 并发 ARDS 与多重耐药 4MRGN 细菌株合并感染患者的单核细胞人类白细胞抗原 DR 功能。
Front Immunol. 2021 Nov 1;12:753849. doi: 10.3389/fimmu.2021.753849. eCollection 2021.
7
Innate immunity and interferon in SARS-CoV-2 infection outcome.先天免疫与 SARS-CoV-2 感染结局中的干扰素。
Immunity. 2023 Jul 11;56(7):1443-1450. doi: 10.1016/j.immuni.2023.06.018.
8
Risk of subsequent SARS-CoV-2 infection among vaccinated employees with or without hybrid immunity acquired early in the Omicron-predominant era of the COVID-19 pandemic.奥密克戎主导的 COVID-19 大流行早期，具有或不具有混合免疫的接种疫苗员工中 SARS-CoV-2 后续感染的风险。
Am J Ind Med. 2024 Apr;67(4):334-340. doi: 10.1002/ajim.23570. Epub 2024 Feb 5.
9
Lymphocyte Phenotyping and HLA-DR Expression over the Course of COVID-19 Infection in Patients with Different Disease Severity.淋巴细胞表型和 HLA-DR 表达在不同疾病严重程度的 COVID-19 感染患者中的变化。
Clin Lab. 2022 May 1;68(5). doi: 10.7754/Clin.Lab.2021.211017.
10
Leveraging Polio Geographic Information System Platforms in the African Region for Mitigating COVID-19 Contact Tracing and Surveillance Challenges: Viewpoint.利用非洲区域脊灰地理信息系统平台缓解 COVID-19 接触者追踪和监测挑战：观点。
JMIR Mhealth Uhealth. 2022 Mar 17;10(3):e22544. doi: 10.2196/22544.

引用本文的文献

1
Seroprevalence Trends of Antibodies to SARS-CoV-2 in South Korea, 2021-2022: A Repeated Cross-Sectional Study.2021 - 2022年韩国新型冠状病毒抗体血清流行趋势：一项重复横断面研究
Influenza Other Respir Viruses. 2025 Jun;19(6):e70117. doi: 10.1111/irv.70117.

本文引用的文献

1
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.全球 2020 年 1 月至 2022 年 4 月 SARS-CoV-2 血清流行率：基于人群的标准化研究的系统评价和荟萃分析。
PLoS Med. 2022 Nov 10;19(11):e1004107. doi: 10.1371/journal.pmed.1004107. eCollection 2022 Nov.
2
Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors.利用献血者血液中的半定量抗体检测预测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体在完全血清阳性人群中的传播情况
Vaccines (Basel). 2022 Aug 31;10(9):1437. doi: 10.3390/vaccines10091437.
3
T cell immunity to COVID-19 vaccines.T 细胞对 COVID-19 疫苗的免疫反应。
Science. 2022 Aug 19;377(6608):821-822. doi: 10.1126/science.add2897. Epub 2022 Aug 18.
4
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.SARS-CoV-2 核衣壳抗体的纵向动力学、血清学转换及其对血清流行病学研究的意义。
Emerg Infect Dis. 2022 Sep;28(9):1859-1862. doi: 10.3201/eid2809.220729. Epub 2022 Jul 22.
5
Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.人群中 SARS-CoV-2 的暴露水平比血清流行率调查所显示的要高得多。
PLoS Comput Biol. 2021 Sep 20;17(9):e1009436. doi: 10.1371/journal.pcbi.1009436. eCollection 2021 Sep.
6
Challenges in control of COVID-19: short doubling time and long delay to effect of interventions.控制 COVID-19 的挑战：短的倍增时间和干预效果的长延迟。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200264. doi: 10.1098/rstb.2020.0264. Epub 2021 May 31.
7
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
8
Infection fatality rate of COVID-19 inferred from seroprevalence data.基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.